Development of High-Performance Contact Lenses and Medical and Pharmaceutical Products

「The company has publicly released an advanced general-purpose platform for electronic-device contact lenses, or smart contact lenses, and plans to address future demand for smart contact lenses in various fields through joint research and development with companies, universities and other research institutions.」

「As a new initiative, the company publicly released an advanced general-purpose platform for contact lenses incorporating electronic devices, or smart contact lenses, in February 2025, and is soliciting ideas and proposals for joint development from advanced technology companies and research institutions worldwide.」

「The company has successfully standardized the technology for integrating various electronic components, including antennas and semiconductor chips, as well as large-scale integrated circuits, into contact lenses, and developed large-scale integrated circuits capable of generally driving a wide range of devices. It has converted this technology into a platform and disclosed it publicly.」

「Domestic contact lens sales continued to focus on the domestically manufactured “SEED 1dayPure Series,” while the company concentrated on expanding sales of high-value-added products such as silicone hydrogel lenses with 2 different characteristics and multifocal contact lenses, whose market is expected to grow particularly strongly. Although demand for the “SEED 1dayPure Series” increased, lost sales opportunities due to delivery delays for domestic and overseas astigmatism and multifocal products, which have continued since the second quarter of the fiscal year ending March 2024, weighed heavily on results, limiting growth to 3.2% year on year. Orthokeratology lenses, worn during sleep to provide vision correction during the day without glasses or contact lenses, grew sharply, up 22.2% year on year.」

「Orthokeratology lenses, worn during sleep to provide vision correction during the day without glasses or contact lenses, grew sharply, up 14.9% year on year.」

「The “1day Pure Series” increased 8.2% year on year on stronger demand. Orthokeratology lenses, worn during sleep to provide vision correction during the day without glasses or contact lenses, also grew sharply, up 13.0% year on year.」

「③ Clinical trials have begun for soft contact lenses that continuously release medication. ... ④ For new smart contact lenses that enable biometric information monitoring, the company is advancing research and development focused on electronic devices and the underlying general-purpose electronics. ... ⑥ In response to growing global interest in medical treatments to control myopia progression, the company has begun clinical trials aimed at commercializing related products.」

「The company continued to focus on expanding sales of high-value-added products, including multifocal contact lenses, whose market is expected to grow significantly, and medical orthokeratology lenses. The orthokeratology lens market grew steadily, with sales up 20.9% year on year, while multifocal contact lenses also grew sharply, up 16.9%.」

「To increase its share of the daily disposable market by adding 2 silicone hydrogel lenses with different characteristics to its lineup, the company launched the OEM-supplied “SEED AirGrade 1day UV W-Moisture (AirGrade 1day UV Double Moisture)” on 23 August 2022.」

「The OEM-supplied “SEED AirGrade 1day UV W-Moisture (AirGrade 1day UV Double Moisture),” scheduled for launch on 23 August, is a daily disposable silicone hydrogel lens with characteristics distinct from “SEED 1daySilfa,” including high oxygen permeability of Dk/L=187, dual moisturizing ingredients and eye-friendly UV protection. By offering the market two silicone hydrogel lenses with different characteristics, the company aims to strengthen its competitiveness in the silicone lens category.」

「③ For soft contact lenses that continuously release medication, the company has completed the selection of target diseases and drugs and begun clinical trials. ... ⑥ In response to growing global interest in medical treatments to control myopia progression, the company is accelerating research and development aimed at commercializing related products.」

「The company continued to focus on its core domestically manufactured “1day Pure Series,” particularly expanding sales of high-value-added products such as multifocal contact lenses and orthokeratology lenses, which are expected to see the strongest market growth. As a result, total contact lens sales were in line with plan, while orthokeratology grew sharply, up 41.3% year on year.」

「The company continued to focus on its core domestically manufactured “1day Pure Series,” particularly expanding sales of high-value-added products such as multifocal contact lenses and orthokeratology lenses, which are expected to see the strongest market growth.」

「The company continued to focus on its core domestically manufactured “1day Pure Series,” particularly expanding sales of technical lens products such as multifocal lenses. The orthokeratology lens business also made steady progress despite the spread of infectious disease, rising 27.0% year on year.」

「④ The company is accelerating research and development of new smart contact lenses that enable biometric information monitoring.」

「In December 2019, the company launched “SEED 1dayPure EDOF (EDOF),” a new multifocal type in the domestically manufactured daily disposable “1day Pure Series.”」

「In addition to continued growth in high-value-added products such as lenses for astigmatism and presbyopia, the myopia and hyperopia products in the “1day Pure Series” also performed well, supported by rush demand ahead of the consumption tax increase.」

「As a core category, daily disposable contact lenses, the “1day Pure Series” continued to grow, led by lenses for astigmatism.」

「The company plans to launch a new multifocal lens product featuring a completely new optical design, add products to its existing lineup, strengthen its orthokeratology business under a joint commercialization agreement with TORAY INDUSTRIES,INC. and 株式会社ユニバーサルビュー, and begin overseas sales of its first daily disposable silicone hydrogel contact lens.」

「In its domestically manufactured disposable Pure series, the company focused on sales of high-value-added products, including “SEED 1dayPure Moisture Plus Flex,” launched in July, and lenses for astigmatism and presbyopia, leveraging its high quality and ability to provide detailed support.」

「The company launched “SEED 1dayPure Moisture Plus Flex,” a contact lens based on a new concept focused on viewing near objects in line with modern lifestyles. In August, it launched “Wan Tact,” a contact lens for protecting dogs’ corneas, and also launched the fashion-oriented “JILL STUART 1day UV,” a collaboration with an apparel brand.」

「We intend to advance the development of higher-quality contact lenses by leveraging the advanced lens-design technologies and optical-analysis expertise of both companies, while strengthening sales in the UK and Irish markets, Europe's largest disposable contact lens market.」

「The lineup of domestically manufactured disposable contact lenses in the Pure series centers on daily disposable lenses for myopia, astigmatism and presbyopia, as well as the two-week replacement “2week Pure Moisture Plus,” whose version was upgraded from January 2016 to improve moisture retention.」

「Competition among manufacturers remains intense, amid the diversification of new-material product lineups, expanded specifications for multifocal lenses and continued entry into the circle lens category.」

「The lineup centers on daily disposable lenses for myopia, astigmatism and presbyopia, as well as the two-week replacement type “2week Pure Moisture Plus,” whose version was upgraded from January 2016 to improve moisture retention.」

「Competition among manufacturers is intensifying, including through the launch of new silicone hydrogel products and the strengthening of offerings for astigmatism and presbyopia.」

「To remain competitive under these conditions, the company needs to develop contact lenses that deliver higher performance and greater wearing comfort by using new materials, develop medical and pharmaceutical products that draw on its contact lens expertise, and establish product specifications that steadily address increasingly specialized needs.」